Paolo Maggi

Summary

Publications

  1. ncbi request reprint Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study
    Paolo Maggi
    Infectious Disease Clinic, Policlinico, University of Bari, Italy
    AIDS 18:1023-8. 2004
  2. ncbi request reprint A color Doppler ultrasound-based comparative study between stavudine and non-stavudine regimens in the onset of vascular lesions in HIV-1-positive patients
    Paolo Maggi
    Clinica delle Malattie Infettive, Universita di Bari, Italy
    In Vivo 22:489-92. 2008
  3. ncbi request reprint Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients
    Paolo Maggi
    Institute of Infectious Diseases, University of Bari, Bari, Italy
    In Vivo 31:125-131. 2017
  4. ncbi request reprint Prevalence and Risk Factors for Significant Liver Fibrosis in Patients with HIV Infection
    Paolo Maggi
    Institute of Infectious Disease, University of Bari, Bari, Italy
    In Vivo 29:771-5. 2015
  5. doi request reprint Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study
    Paolo Maggi
    Institute of Infectious Diseases, Policlinico University of Bari, Bari, Italy
    J Antimicrob Chemother 70:1150-4. 2015
  6. ncbi request reprint Renal complications in HIV disease: between present and future
    Paolo Maggi
    Clinic of Infectious Disease, University Hospital, Bari, Italy
    AIDS Rev 14:37-53. 2012
  7. pmc Plasmodium falciparum malaria and Parvovirus B19; a case of acute co-infection
    F Ingrassia
    Institute of Infectious Diseases, University of Bari, Italy
    BMC Infect Dis 10:87. 2010
  8. ncbi request reprint Leishmaniasis in patients with chronic renal failure: a diagnostic and therapeutic challenge for the clinician
    Paolo Maggi
    Clinic for Infectious Diseases, University of Bari, Bari, Italy
    J Nephrol 17:296-301. 2004
  9. ncbi request reprint Cutaneous injection site reactions to long-term therapy with enfuvirtide
    Paolo Maggi
    Clinica delle Malattie Infettive, Policlinico University of Bari Italy, Bari 70124
    J Antimicrob Chemother 53:678-81. 2004
  10. doi request reprint Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir
    Paolo Maggi
    Division of Infectious Disease, University of Bari, Bari, Italy
    AIDS Patient Care STDS 26:5-11. 2012

Collaborators

Detail Information

Publications34

  1. ncbi request reprint Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study
    Paolo Maggi
    Infectious Disease Clinic, Policlinico, University of Bari, Italy
    AIDS 18:1023-8. 2004
    ..To evaluate the correlation between antiretroviral therapy (ART) and lesions of the carotid vessels using an ultrasound colour-Doppler technique...
  2. ncbi request reprint A color Doppler ultrasound-based comparative study between stavudine and non-stavudine regimens in the onset of vascular lesions in HIV-1-positive patients
    Paolo Maggi
    Clinica delle Malattie Infettive, Universita di Bari, Italy
    In Vivo 22:489-92. 2008
    ..The present study aimed to investigate the role of stavudine in the onset of premature vascular lesions using an ultrasound color Doppler evaluation of the carotid vessels...
  3. ncbi request reprint Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients
    Paolo Maggi
    Institute of Infectious Diseases, University of Bari, Bari, Italy
    In Vivo 31:125-131. 2017
    ....
  4. ncbi request reprint Prevalence and Risk Factors for Significant Liver Fibrosis in Patients with HIV Infection
    Paolo Maggi
    Institute of Infectious Disease, University of Bari, Bari, Italy
    In Vivo 29:771-5. 2015
    ..The aim of the present study was the evaluation of liver fibrosis in a population of patients monoinfected with HIV using the transient liver elastography (FibroScan) method...
  5. doi request reprint Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study
    Paolo Maggi
    Institute of Infectious Diseases, Policlinico University of Bari, Bari, Italy
    J Antimicrob Chemother 70:1150-4. 2015
    ..The aim of the present study was to evaluate markers of osteorenal toxicity in patients affected by hepatitis B virus-related chronic hepatitis treated with lamivudine plus adefovir who were switched to tenofovir...
  6. ncbi request reprint Renal complications in HIV disease: between present and future
    Paolo Maggi
    Clinic of Infectious Disease, University Hospital, Bari, Italy
    AIDS Rev 14:37-53. 2012
    ..Finally, we discuss future perspectives of renal damage in HIV patients and evaluate the patient's perspective...
  7. pmc Plasmodium falciparum malaria and Parvovirus B19; a case of acute co-infection
    F Ingrassia
    Institute of Infectious Diseases, University of Bari, Italy
    BMC Infect Dis 10:87. 2010
    ..Herein we describe a case of acute co-infection with severe anemia and renal failure...
  8. ncbi request reprint Leishmaniasis in patients with chronic renal failure: a diagnostic and therapeutic challenge for the clinician
    Paolo Maggi
    Clinic for Infectious Diseases, University of Bari, Bari, Italy
    J Nephrol 17:296-301. 2004
    ..In this study, the authors present a series of three cases of leishmaniasis (one visceral, one mucous and one muco-visceral) in patients with end-stage renal failure characterized by an atypical presentation and/or resistance to therapy...
  9. ncbi request reprint Cutaneous injection site reactions to long-term therapy with enfuvirtide
    Paolo Maggi
    Clinica delle Malattie Infettive, Policlinico University of Bari Italy, Bari 70124
    J Antimicrob Chemother 53:678-81. 2004
    ..The drug is safe and well tolerated; injection site reactions are the most common adverse events. The aim of this study was the clinical and histopathological evaluation of injection site reactions in patients treated for 80 weeks...
  10. doi request reprint Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir
    Paolo Maggi
    Division of Infectious Disease, University of Bari, Bari, Italy
    AIDS Patient Care STDS 26:5-11. 2012
    ..In conclusion, TDF may be associated with subclinical mitochondrial damage, inducing at a later stage increased urinary excretion of phosphate and uric acid, as markers of incipient tubular injury...
  11. doi request reprint Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens
    Paolo Maggi
    Institute of Infectious Diseases, Policlinico, University of Bari, Bari, Italy
    J Antimicrob Chemother 66:896-900. 2011
    ..The aim of this study was to evaluate the cardiovascular risk among patients treated for more than 5 years with regimens based on nevirapine or efavirenz...
  12. ncbi request reprint B-mode ultrasound study of carotid plaques in HIV-positive patients to detect the presence of inflammatory endothelial lesions
    Paolo Maggi
    Institute of Infectious Diseases and Chair of Vascular Surgery, University of Bari, Italy
    Curr HIV Res 7:541-6. 2009
    ..No significant differences were found between HIV-positive and arteritis patients. This ultrasonographic study confirms that inflammatory mechanisms could play a major role in the onset of vascular damage in HIV-1 positive patients...
  13. doi request reprint Functional impairments of microcirculation in HIV-positive patients: a laser Doppler fluxometry-based investigation
    Paolo Maggi
    Institute of Infectious Diseases, University of Bari, Bari, Italy
    HIV Clin Trials 9:428-33. 2008
    ..Microcirculation was investigated by means of capillaroscopy and laser Doppler fluxometry (LDF). The results were compared with those obtained from healthy subjects and patients affected by sclerodermia...
  14. ncbi request reprint Does iatrogenic scleroderma due to injection-site reaction to enfuvirtide impair absorption of the drug?
    Paolo Maggi
    Clinica delle Malattie Infettive, University of Bari, Bari, Italy
    Clin Drug Investig 28:305-11. 2008
    ..This study correlated the clinical and histopathological pattern of injection-site reactions (ISRs) to the pharmacokinetics of enfuvirtide in patients with HIV...
  15. ncbi request reprint Atherosclerosis in HIV patients: a new face for an old disease?
    Paolo Maggi
    Clinica delle Malattie Infettive, Policlinico di Bari, Istituto di Malattie Infettive, Italy
    AIDS Rev 8:204-9. 2006
    ..The lesions in the first phase are probably determined by immunodeficiency, immune reconstitution, and the same effect of HAART. In the second phase they could be maintained by the classic risk factors...
  16. ncbi request reprint An ultrasound-based comparative study on carotid plaques in HIV-positive patients vs. atherosclerotic and arteritis patients: atherosclerotic or inflammatory lesions?
    Paolo Maggi
    Institute of Infectious Diseases, University of Bari, Bari, Italy
    Coron Artery Dis 18:23-9. 2007
    ..The results were compared with those obtained from young patients affected by atherosclerosis of the epi-aortic vessels and patients with arteritis...
  17. ncbi request reprint Role of chlamydia infection in the pathogenesis of atherosclerotic plaques in HIV-1-positive patients
    Paolo Maggi
    Departments of Clinical Medicine, Immunology and Infectious Diseases Infectious Disease section, Naples, Italy
    In Vivo 20:409-13. 2006
    ....
  18. ncbi request reprint Rapid progression of carotid lesions in HAART-treated HIV-1 patients
    Paolo Maggi
    Institute of Infectious Diseases, University of Bari, Italy
    Atherosclerosis 192:407-12. 2007
    ..The shift from PIs to NNRTI/3 NRTI seems related to a lower rate of evolution. Interestingly, a disappearance of lesions was detected in both groups...
  19. ncbi request reprint Novel antiretroviral drugs and renal function monitoring of HIV patients
    Paolo Maggi
    Clinic of Infectious Diseases, University Hospital Policlinico, Bari, Italy
    AIDS Rev 16:144-51. 2014
    ..Also, tubular function needs to be carefully monitored with simple tests such as proteinuria, phosphatemia, urinary excretion of phosphate, normoglycemic glycosuria, and excretion of uric acid. ..
  20. doi request reprint Cardiovascular risk assessment in antiretroviral-naïve HIV patients
    Paolo Maggi
    Clinica delle Malattie Infettive, Universita degli Studi di Bari Policlinico, Bari, Italy p_maggi_yahoo com
    AIDS Patient Care STDS 23:809-13. 2009
    ..Our data support the hypothesis that HIV infection per se is a risk factor for atherosclerosis. We recommend an ultrasonographic assessment both among patients with FRS 6% or more and among those in advanced stage of disease...
  21. ncbi request reprint Real life experience in treatment of HIV-1/HCV-coinfected patients with pegylated interferon alpha and ribavirin: predictors of SVR
    Giuseppe Bruno
    Clinic of Infectious Diseases, University of Bari, Italy
    New Microbiol 38:21-7. 2015
    ....
  22. doi request reprint The problem of renal function monitoring in patients treated with the novel antiretroviral drugs
    Paolo Maggi
    Clinic of Infectious Diseases, University Hospital Policlinico, Bari, Italy
    HIV Clin Trials 15:87-91. 2014
    ..HIV patients treated by the novel drugs need to be monitored on a monthly basis for the first 3 months. Subsequent monitoring should be performed on a quarterly basis or guided by comorbidities. ..
  23. doi request reprint Digital laser doppler flowmetry may discriminate "limited" from "diffuse" systemic sclerosis
    Vito Grattagliano
    DIMIMP, Rheumatology Unit, Clinica delle Malattie Infettive, University of Bari, Italy
    Microvasc Res 80:221-6. 2010
    ..To investigate skin blood flux and microvascular functional changes by laser Doppler flowmetry (LD) in patients with systemic sclerosis (SSc) at baseline and following dynamic stimulations...
  24. doi request reprint Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?
    Laura A Nicolini
    aDepartment of Social Health DISSAL, Division of Infectious Disease, University of Genoa IRCCS San Martino IST, Genoa bUnit of Infectious Diseases, Busto Arsizio Hospital, Busto Arsizio cEpi2004, Luigi Sacco Hospital dDepartment of Infectious Diseases, Luigi Sacco Hospital, Milan eInfectious Diseases Unit, AOU Careggi, Florence fInstitute of Infectious Disease, University of Bari, Bari gDepartment of Clinical and Molecular Biomedicine, Division of Infectious Diseases, University of Catania, Catania hDivision of Infectious Diseases, Santo Spirito Hospital, Pescara iDepartment of Clinical and Experimental Medicine, University of Sassari, Sassari jInfectious Diseases Unit, A Manzoni Hospital, Lecco kInfectious Diseases Clinic, Universita G D Annunzio, Chieti lUnit of Infectious Diseases, Santa Maria Annunziata Hospital, Firenze mDepartment of Infectious Diseases, Santa Maria Hospital, Perugia, Italy
    Eur J Gastroenterol Hepatol 28:37-41. 2016
    ..The aim of this study was to assess the effectiveness of telaprevir-based and boceprevir-based treatments with respect to the HIV status...
  25. pmc Epi-aortic lesions, pathologic FMD, endothelial activation and inflammatory markers in advanced naïve HIV-infected patients starting ART therapy
    Chiara Bellacosa
    Clinical Infectious Diseases, University of Bari, Policlinico Consorziale, Bari, Italy
    J Int AIDS Soc 17:19545. 2014
    ....
  26. ncbi request reprint Toxoplasmosis in Kosovo pregnant women
    Pietro Dentico
    Department of Internal Medicine, Immunology and Infectious Diseases, University of Bari, Bari, Italy
    New Microbiol 34:203-7. 2011
    ....
  27. doi request reprint Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study
    Giuseppe Vittorio De Socio
    aUnit of Infectious Diseases, Department of Medicine, Azienda Ospedaliero Universitaria di Perugia, Santa Maria Hospital, PerugiabDepartment of Infectious Diseases, Luigi Sacco Hospital, MilancUnit of Infectious Diseases, University of Bari, BaridDepartment of Infectious Diseases, Pescara Hospital, PescaraeUnit of Infectious Diseases, Garibaldi Hospital, University of Catania, CataniafDepartment of Infectious Diseases, Amedeo di Savoia Hospital, TuringDepartment of Clinical and Experimental Medicine, University of Sassari, SassarihDepartment of Infectious Diseases, Careggi Hospital, FlorenceiUnit of Infectious Diseases, Busto Arsizio Hospital, Busto ArsiziojInfectious Diseases, San Marino University Hospital, GenoakUnit of Infectious Diseases, Manzoni Hospital, LeccolDepartment of Medicine, University of Perugia and Unit of Internal Medicine, Santa Maria Hospital, Terni, University of Perugia, Perugia, Italy
    J Hypertens 35:409-416. 2017
    ..We also evaluated predictors of cardiovascular events and of new-onset hypertension...
  28. doi request reprint Decreasing cardiovascular risk in HIV infection between 2005 and 2011
    Giuseppe V De Socio
    aDepartment of Infectious Diseases, Azienda Ospedaliero Universitaria di Perugia, Perugia bDepartment of Infectious Diseases, Pescara Hospital, Pescara cDepartment of Infectious Diseases, Luigi Sacco Hospital, Milan dDepartment of Infectious Diseases, University of Bari, Bari eDepartment of Infectious Diseases, Garibaldi Hospital, University of Catania, Catania fDepartment of Infectious Diseases, Galliera Hospital, Genoa, Genoa gDepartment of Infectious Diseases, Careggi Hospital, Florence hDepartment of Infectious Diseases, University of Milan, Milan iDepartment of Infectious Diseases, San Martino Hospital Genoa, University of Genoa, Genoa jDepartment of Infectious Diseases, Manzoni Hospital, Lecco kUniversità di Perugia and Struttura Complessa di Medicina Interna, Azienda Ospedaliero Universitaria di Terni, Terni, Italy
    AIDS 28:609-12. 2014
    ..3% vs. 33.4% (P = 0.006). Blood glucose, triglycerides, prevalence of smokers, and lipodystrophy were all significantly lower in 2011 (all P < 0.0001). Cardiovascular risk improved over a 6-year period in Italian HIV-infected patients...
  29. doi request reprint Fatal fulminant hepatitis following administration of clarithromycin in a patient chronically treated with antipsycotic drugs
    Paolo Maggi
    Clinic of Infectious Disease, University Hospital, Bari, Italy
    Immunopharmacol Immunotoxicol 35:191-4. 2013
    ..Clarithromycin is a widely used antibiotic, especially prescribed for the treatment of respiratory tract infections, The drug is generally well tolerated. It is described as a very rare cause of fulminant liver failure...
  30. ncbi request reprint Surveillance of toxoplasmosis in pregnant women in Albania
    Paolo Maggi
    Institute of Infectious Disease, University of Bari, Italy
    New Microbiol 32:89-92. 2009
    ....
  31. ncbi request reprint A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regi
    Carlo Torti
    Institute for Infectious and Tropical Diseases, Brescia, Italy
    Clin Infect Dis 40:1828-36. 2005
    ....
  32. ncbi request reprint Premature vascular lesions in HIV-positive patients: a clockwork bomb that will explode?
    Paolo Maggi
    AIDS 16:947-8. 2002
  33. ncbi request reprint Acute onset of non-Hodgkin's lymphoma with bowel perforation in a patient with over 15 years' HIV positivity. A case report
    Luigi Greco
    Department of Emergency and Organ Transplantation, University of Bari
    Chir Ital 54:893-6. 2002
    ..The histological diagnosis was large-cell non-Hodgkin's lymphoma type B. After the operation, the patient was treated by chemotherapy and, currently, after a 12-month follow-up, is in good general condition...
  34. ncbi request reprint Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors
    Nicola Petrosillo
    Istituto Nazionale per le Malattie Infettive L Spallanzani, Istituto di Ricovero e Cura a Carattere Scientifico, 00149 Rome, Italy
    Clin Infect Dis 34:677-85. 2002
    ..6% and 7.2% among patients with and without NBSIs, respectively (P<.00001). In the era of highly active antiretroviral therapy, NBSIs continue to occur frequently and remain severe and life-threatening manifestations...